118 related articles for article (PubMed ID: 419961)
1. Hyperthecosis syndrome. Clinical, endocrinologic and histologic findings.
Karam K; Hajj S
Acta Obstet Gynecol Scand; 1979; 58(1):73-9. PubMed ID: 419961
[TBL] [Abstract][Full Text] [Related]
2. Familial hyperthecosis: comparison of endocrinologic and histologic findings with polycystic ovarian disease.
Judd HL; Scully RE; Herbst AL; Yen SS; Ingersol FM; Kliman B
Am J Obstet Gynecol; 1973 Dec; 117(7):976-82. PubMed ID: 4759835
[No Abstract] [Full Text] [Related]
3. Ovarian hyperthecosis in the adolescent patient.
Wentz AC; Gutai JP; Jones GS; Migeon CJ
J Pediatr; 1976 Mar; 88(3):488-93. PubMed ID: 1107505
[TBL] [Abstract][Full Text] [Related]
4. Primary polycystic ovary syndrome in a premenarchal girl. A case report.
Rao JK; Chihal HJ; Johnson CM
J Reprod Med; 1985 Apr; 30(4):361-5. PubMed ID: 3925138
[TBL] [Abstract][Full Text] [Related]
5. Luteinizing hormone, adrenal androgenesis, and polycystic ovarian disease.
Polansky S
Obstet Gynecol; 1975 Apr; 45(4):451-4. PubMed ID: 1121374
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive.
Givens JR; Andersen RN; Wiser WL; Fish SA
J Clin Endocrinol Metab; 1974 May; 38(5):727-35. PubMed ID: 4823918
[No Abstract] [Full Text] [Related]
7. Response to LH-RH and HCG in two brothers with the Reifenstein syndrome.
Flatau E; Josefsberg Z; Prager-Lewin R; Markman-Halabe E; Kaufman H; Laron Z
Helv Paediatr Acta; 1976 Jan; 30(4-5):377-83. PubMed ID: 1107277
[TBL] [Abstract][Full Text] [Related]
8. [Hyperthecosis ovarii--a tumor-like change in androgenized females].
Schwartz U; Moltz L; Pickartz H; Sörensen R; Römmler A
Geburtshilfe Frauenheilkd; 1986 Jun; 46(6):391-7. PubMed ID: 3091442
[TBL] [Abstract][Full Text] [Related]
9. The androgenic polycystic ovary.
Greenblatt RB; Mahesh VB
Am J Obstet Gynecol; 1976 Jul; 125(5):712-26. PubMed ID: 180807
[TBL] [Abstract][Full Text] [Related]
10. Ovarian response patterns to human menopausal gonadotropin in mixed hyperandrogenemia.
Hamori M; Török A; Zwirner M; Tinneberg HR
Acta Endocrinol (Copenh); 1990 Dec; 123(6):598-602. PubMed ID: 2149487
[TBL] [Abstract][Full Text] [Related]
11. Hyperthecosis syndrome.
Farber M; Daoust PR; Rogers J
Obstet Gynecol; 1974 Jul; 44(1):35-41. PubMed ID: 4834796
[No Abstract] [Full Text] [Related]
12. Clinical findings and hormonal responses in patients with polycystic ovarian disease with normal versus elevated LH levels.
Givens JR; Andersen RN; Umstot ES; Wiser WL
Obstet Gynecol; 1976 Apr; 47(4):388-94. PubMed ID: 1256723
[TBL] [Abstract][Full Text] [Related]
13. [Effect of dexamethasone on blood levels of FSH, LH, PRL and testosterone in patients with Stein-Leventhal syndrome before and after wedge resection of the ovaries].
Zieleniewski J; Reterski Z; Owczarczyk I
Ginekol Pol; 1982; 53(7-8):505-10. PubMed ID: 6820647
[No Abstract] [Full Text] [Related]
14. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
[TBL] [Abstract][Full Text] [Related]
15. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
[TBL] [Abstract][Full Text] [Related]
16. The utility and selection of laboratory tests in the diagnosis of the polycystic ovary syndrome.
Deutsch S; Krumholz B; Benjamin I
J Reprod Med; 1978 May; 20(5):275-82. PubMed ID: 671401
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovarian disease.
Goldzieher JW
Clin Obstet Gynecol; 1973 Dec; 16(4):82-105. PubMed ID: 4593954
[No Abstract] [Full Text] [Related]
18. The role of endogenous gonadotropin release in the etiology of ovarian enlargement during purified urinary follicle-stimulating hormone therapy.
Mizunuma H; Takagi T; Yamada K; Andoh K; Ibuki Y; Igarashi M
Fertil Steril; 1991 Jan; 55(1):66-72. PubMed ID: 1898893
[TBL] [Abstract][Full Text] [Related]
19. Serum LH and FSH levels in women with polycystic ovary syndrome before and after ovarian wedge resection.
Shterev AD; Dokumov SI
Endocrinologie; 1982; 20(3):203-7. PubMed ID: 6815773
[TBL] [Abstract][Full Text] [Related]
20. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1994 Jul; 79(1):119-25. PubMed ID: 8027216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
